Glendon E. French III - 01 Dec 2025 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role: President and CEO, Director
Signature: /s/ David Aaron Lehman, Attorney-in-Fact
Issuer symbol: LUNG
Transactions as of: 01 Dec 2025
Net transactions value: -$13,824
Form type: 4
Filing time: 03 Dec 2025, 19:51:47 UTC
Previous filing: 04 Jun 2025
Next filing: 09 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
French Glendon E. III	President and CEO, Director	C/O PULMONX CORPORATION, 700 CHESAPEAKE DRIVE, REDWOOD CITY	/s/ David Aaron Lehman, Attorney-in-Fact	02 Dec 2025	0001805624

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LUNG	Common Stock	Sale	$3,963	-2,524	-0.88%	$1.57	283,605	01 Dec 2025	Direct	F1
transaction	LUNG	Common Stock	Sale	$9,861	-6,281	-2.2%	$1.57	277,324	01 Dec 2025	Direct	F2
transaction	LUNG	Common Stock	Award	$0	+1,200,000	+433%	$0.000000	1,477,324	01 Dec 2025	Direct	F3
holding	LUNG	Common Stock						742,998	01 Dec 2025	By trust	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LUNG	Performance Stock Units	Award	$0	+800,000		$0.000000	800,000	01 Dec 2025	Common Stock	800,000		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022.
F2	These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
F3	Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
F4	The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.
F5	Each Performance Stock Unit represents a contingent right to receive one share of the Issuer's common stock. The Performance Stock Units vest upon meeting the following two conditions: (a) upon the Issuer's common stock achieving a specified price per share and (b) with respect to 33% on the one year following the grant date of December 1, 2025 and the remainder in eight equal quarterly installments.